ABSTRACT
As Marcelo Giugale published in the Financial Times, Latin America, on the whole, has not excelled at innovation - doing the same things in a new and better way or at doing new things. It has been slow to acquire, adopt and adapt technologies by this time available in other places[11 Giugale M. Creativity is key if Latin America is to progress. Financial Times. 2010 Nov 22 [cited 2015 Oct 15]. Available from: http://www.ft.com/cms/s/2/f72e9d1e-f655-11df-846a-00144feab49a.html#axzz3t60GrzmU
http://www.ft.com/cms/s/2/f72e9d1e-f655-...
]. Although extracorporeal membrane oxygenation (ECMO) is not a new technology, its use in Latin America is not widespread as needed. Furthermore, we still have a number centers doing ECMO, not reporting their cases, lacking a structured training program and not registered with the extracorporeal life support organization (ELSO). With this scenario, and accepting that ECMO is the first step in any circulatory support program, it is difficult to anticipate the incorporation of new and more complex devices as the technologically advanced world is currently doing. However, the good news is that with the support of experts from USA, Europe and Canada the results in Latin America ELSO'S centers are improving by following its guidelines for training, and using a standard educational process. There is no doubt that we can learn a great deal from the high velocity organizations - the rabbits - whom everyone chases but never catches, that manage to stay ahead because of their endurance, responsiveness, and their velocity in self-correction[22 Spear SJ. Chasing the rabbit: how market leaders outdistance the competition and how great companies can catch up and win. New York: McGraw-Hill; 2008. 432p.].
Keywords:
Extracorporeal Membrane Oxygenation; Heart Defects, Congenital; Cardiovascular Surgical Procedures; Technology